118 related articles for article (PubMed ID: 14974111)
1. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients.
Farina A; Sekizawa A; Sugito Y; Iwasaki M; Jimbo M; Saito H; Okai T
Prenat Diagn; 2004 Feb; 24(2):83-6. PubMed ID: 14974111
[TBL] [Abstract][Full Text] [Related]
2. Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening.
Farina A; Sekizawa A; Iwasaki M; Matsuoka R; Ichizuka K; Okai T
Prenat Diagn; 2004 Sep; 24(9):722-6. PubMed ID: 15386446
[TBL] [Abstract][Full Text] [Related]
3. Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood.
Farina A; Sekizawa A; Rizzo N; Concu M; Banzola I; Carinci P; Simonazzi G; Okai T
Prenat Diagn; 2004 Apr; 24(4):293-7. PubMed ID: 15065105
[TBL] [Abstract][Full Text] [Related]
4. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
[TBL] [Abstract][Full Text] [Related]
5. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction.
Alberry MS; Maddocks DG; Hadi MA; Metawi H; Hunt LP; Abdel-Fattah SA; Avent ND; Soothill PW
Am J Obstet Gynecol; 2009 Jan; 200(1):98.e1-6. PubMed ID: 19121662
[TBL] [Abstract][Full Text] [Related]
6. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia.
Cotter AM; Martin CM; O'leary JJ; Daly SF
Am J Obstet Gynecol; 2004 Aug; 191(2):515-20. PubMed ID: 15343229
[TBL] [Abstract][Full Text] [Related]
7. [Study on the relation between concentration of circulating non-host fetal DNA in pregnant women and pre-eclampsia].
Tao H; Wang XM; Ji XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):808-11. PubMed ID: 16412324
[TBL] [Abstract][Full Text] [Related]
8. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia.
Zhong XY; Laivuori H; Livingston JC; Ylikorkala O; Sibai BM; Holzgreve W; Hahn S
Am J Obstet Gynecol; 2001 Feb; 184(3):414-9. PubMed ID: 11228496
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the female fetal DNA concentration in the plasma of the pregnant women as preeclampsia indicator--preliminary report.
Karina E; Tomasz P; Bilar M; Agnieszka O; Ewa B; Elzbieta RW
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):165-8. PubMed ID: 19632756
[TBL] [Abstract][Full Text] [Related]
10. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk.
Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K
Prenat Diagn; 2009 Aug; 29(8):781-9. PubMed ID: 19418482
[TBL] [Abstract][Full Text] [Related]
11. Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma.
Purwosunu Y; Sekizawa A; Okazaki S; Farina A; Wibowo N; Nakamura M; Rizzo N; Saito H; Okai T
Am J Obstet Gynecol; 2009 Apr; 200(4):386.e1-7. PubMed ID: 19217595
[TBL] [Abstract][Full Text] [Related]
12. The analysis of the correlation between extracellular fetal DNA concentration in maternal circulation and severity of preeclampsia.
Engel K; Płonka T; Bilar M; Czajkowska E; Orzińska E; Brojer E; Ronin-Walknowska E
Ann Acad Med Stetin; 2007; 53(3):20-5. PubMed ID: 18595481
[TBL] [Abstract][Full Text] [Related]
13. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia.
Zhong XY; Holzgreve W; Hahn S
Hypertens Pregnancy; 2002; 21(1):77-83. PubMed ID: 12044339
[TBL] [Abstract][Full Text] [Related]
14. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
[TBL] [Abstract][Full Text] [Related]
15. First-trimester maternal plasma cell-free fetal DNA and preeclampsia.
Sifakis S; Zaravinos A; Maiz N; Spandidos DA; Nicolaides KH
Am J Obstet Gynecol; 2009 Nov; 201(5):472.e1-7. PubMed ID: 19631923
[TBL] [Abstract][Full Text] [Related]
16. Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia.
Crowley A; Martin C; Fitzpatrick P; Sheils O; O'Herlihy C; O'Leary JJ; Byrne BM
Prenat Diagn; 2007 Feb; 27(2):174-9. PubMed ID: 17191257
[TBL] [Abstract][Full Text] [Related]
17. Fetal DNA quantitation in peripheral blood is not useful as a marker of disease severity in women with preeclampsia.
Byrne BM; Crowley A; Taulo F; Anthony J; O'Leary JJ; O'Herlihy C
Hypertens Pregnancy; 2003; 22(2):157-64. PubMed ID: 12909000
[TBL] [Abstract][Full Text] [Related]
18. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast.
Alberry M; Maddocks D; Jones M; Abdel Hadi M; Abdel-Fattah S; Avent N; Soothill PW
Prenat Diagn; 2007 May; 27(5):415-8. PubMed ID: 17286310
[TBL] [Abstract][Full Text] [Related]
19. Increased fetal RhD gene in the maternal circulation in early pregnancy is associated with an increased risk of pre-eclampsia.
Cotter AM; Martin CM; O'Leary JJ; Daly SF
BJOG; 2005 May; 112(5):584-7. PubMed ID: 15842281
[TBL] [Abstract][Full Text] [Related]
20. Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation.
Banzola I; Farina A; Concu M; Sekizawa A; Purwosunu Y; Strada I; Arcelli D; Simonazzi G; Caramelli E; Rizzo N
Prenat Diagn; 2007 Nov; 27(11):1005-10. PubMed ID: 17654753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
